Skip to content

Drug interactions

Nilotinib + Pitolisant

Severity: Major

Nilotinib and Pitolisant: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both agents can prolong the QTc interval, so concurrent use may increase the risk of ventricular arrhythmias including torsades de pointes. The risk is greater with electrolyte disturbance or cardiac disease.

What this interaction means in plain words

Nilotinib and Pitolisant can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Nilotinib belongs to Oncology; Pitolisant belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic QT prolongation.

What to do

Avoid the combination where possible. If used together, monitor ECG and correct potassium and magnesium.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nilotinib and Pitolisant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Nilotinib with Pitolisant?

MediHelp rates the interaction as major. Nilotinib and Pitolisant can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both agents can prolong the QTc interval, so concurrent use may increase the risk of ventricular arrhythmias including torsades de pointes. The risk is greater with electrolyte disturbance or cardiac disease.

How serious is the interaction between Nilotinib and Pitolisant?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible. If used together, monitor ECG and correct potassium and magnesium.

What other medicines interact with Nilotinib?

MediHelp also lists interactions of Nilotinib with, for example, Amiodarone, Arsenic trioxide, Disopyramide. The full list is on the Nilotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in